Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wuhan Pnq Int Trade Co., Ltd. is a specialized trading company and supplier of chemical products, pharmaceutical intermediates, and health supplements based in Wuhan, China. Established in 2021, the company provides a broad range of high-quality raw materials, including active pharmaceutical ingredients (APIs), nootropics, herbal extracts, and cosmetic peptides such as GHK-Cu and PTD-DBM. Wuhan PNQ serves diverse industries including pharmaceuticals, nutraceuticals, and cosmetics, operating primarily through global B2B platforms like ECHEMI and Alibaba. The company emphasizes rigorous quality control and efficient logistics to support its international clientele in the life sciences and healthcare sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wuhan Pnq Int Trade.